The innovative technology in the treatment of diabetes, the largest chronic non-infectious disease in the world, has been developed by researchers from Santa Barbara. Possibly the most significant advance since local scientists isolated insulin, this innovation is destined to revolutionize the management of the disease.
Currently, controlling diabetes is relentless. To stay alive, people with type 1 diabetes need to take insulin several times a day, 365 days a year. But what would happen if the control could resolve itself, if most blood sugar events, high and low, could be prevented? That is the idea behind the artificial pancreas systems. Life is changing and here today.
Artificial pancreas systems close the gap between two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (MCG) sensor. With an artificial pancreas, a sophisticated computer program, instead of the person with diabetes, calculates the amount of insulin administered by the pump according to the CGM readings. Such a "closed loop system" requires little or possibly no user input and provides discreet real-time information to the user's smartphone application.
Video credits to MIT Enterprise Forum of the Central Coast YouTube channel